The efficacy of follicle stimulating hormone (FSH) as an alternative to luteinizing hormone (LH)/human chorionic gonadotrophin (HCG) for the initiation of periovulatory events in primate follicles is unknown. A single bolus of 2500 IU recombinant (r)-hFSH was compared to 1000 IU r-HCG for its ability to promote oocyte nuclear maturation and fertilization, granulosa cell luteinization and corpus luteum function following r-hFSH (60 IU/day) induction of multiple follicular development in rhesus monkeys. Following the r-hFSH bolus, bioactive luteinizing hormone concentrations were <3 ng/ml. Peak concentrations of serum FSH (1455 ⍨ 314 mIU/ml; mean ⍨ SEM) were attained 2-8 h after r-hFSH, and declined by 96 h. Bioactive HCG concentrations peaked between 2-8 h after r-HCG and remained ജ100 ng/ml for >48 h, while immunoreactive FSH concentrations were at baseline. The proportion of oocytes resuming meiosis and undergoing in-vitro fertilization (IVF) were comparable for r-hFSH (89%; 47 ⍨ 19%) and r-HCG (88%; 50 ⍨ 17%). In-vitro progesterone production and expression of progesterone receptors in granulosa cells did not differ between groups. Peak concentrations of serum progesterone in the luteal phase were similar, but were lower 6-9 days post-FSH relative to HCG. Thus, a bolus of r-hFSH was equivalent to r-HCG for the reinitiation of oocyte meiosis, fertilization and granulosa cell luteinization, but a midcycle FSH surge did not sustain normal luteal function in primates.
Introduction
In many mammalian species, including non-human primates (Weick et al., 1973) and women (Hoff et al., 1983) , a surge of follicle stimulating hormone (FSH) accompanies the surge 554 © European Society for Human Reproduction and Embryology of luteinizing hormone (LH) at midcycle. Nevertheless, the physiological manifestations of the midcycle gonadotrophin surge in the preovulatory follicle, i.e., resumption of oocyte meiosis, ovulation, luteinization of the follicle wall, and early development of the corpus luteum, have been attributed mainly to the action of LH. Although many early studies suggested a role for FSH in ovulation, its relative contribution to the ovulatory process was suspect due to residual LH contamination in the purified FSH preparations used (Lostroh and Johnson, 1966; Harrington and Elton, 1969; Stern and Schuetz, 1970; Sogn et al., 1987; Hubbard and Erickson, 1988; Montgomery et al., 1988) . However, the recent availability of recombinant human (r-h) FSH, devoid of LH activity , permitted studies that confirmed the ability of FSH to supplant the midcycle LH surge for promoting certain periovulatory events in rodents. Ovulation and increased activity of proteolytic enzymes that degrade the follicle wall, as well as luteinization of follicular cells and corpus luteum formation occurred following injection of a bolus of r-hFSH alone in hypophysectomized, gonadotrophin-treated rats and mice (Galway et al., 1990a; Montgomery-Rice et al., 1993; Tapanainen et al., 1993; Wang and Greenwald, 1993a) . During ovarian stimulation cycles in non-human primates (Wolf et al., 1990) and women (Shoham et al., 1995) , human chorionic gonadotrophin (HCG) evolved as a surrogate for the LH surge to promote periovulatory events. The availability and long halflife of this LH-like gonadotrophin made HCG the ovulatory stimulus of choice during controlled ovarian stimulation regimens. However, the long serum half-life of HCG is associated, in part, with certain disadvantages when used clinically for in-vitro fertilization (IVF)-related cycles, including an increased risk of ovarian hyperstimulation syndrome (reviewed in Shoham et al., 1995) . Furthermore, an HCG bolus would not be efficacious for assisted reproduction in patients with ovarian failure due to LH insensitivity, e.g. functional mutations in the LH/CG receptor (Latronico et al., 1996) . The desire for alternative methods that produce a more physiological gonadotrophin surge spurred the investigations on both gonadotrophin-releasing hormone agonists to elicit endogenous LH surges (Shoham et al., 1995) , and exogenous r-hLH (Aladin Chandrasekher et al., 1994; Imthurn et al., 1996) . To date, studies in primates have not been performed to evaluate whether FSH can replace the midcycle LH/CG surge to promote periovulatory events. This study assessed whether a bolus of r-hFSH alone is equivalent to r-HCG for initiating oocyte maturation and fertilization, granulosa cell luteinization, as well as corpus luteum development and function following gonadotrophin stimulation in rhesus monkeys.
Materials and methods

Follicular stimulation
Induction of multiple follicular development in rhesus monkeys was described previously in detail (Zelinski-Wooten et al., 1997) . Briefly, monkeys received daily s.c. treatment with the gonadotrophin-releasing hormone (GnRH) antagonist, Antide (Laboratoires Serono SA, Aubonne, Switzerland), beginning at midluteal phase of a spontaneous menstrual cycle for 7 days. Daily i.m. injections of 60 IU r-hFSH (Gonal F TM , Laboratoires Serono SA) were then initiated with continued Antide treatment. When at least six follicles,~4 mm diameter, were noted at ultrasound, animals (n ϭ 5/group) received a single injection of 1000 IU r-HCG (Laboratoires Serono SA; i.m.) or 2500 IU r-hFSH (Laboratoires Serono SA; s.c.) and a final injection of Antide at 08:00 h the following day. Ultrasonography was also performed on the morning of r-HCG/r-hFSH injection.
Blood samples were collected daily throughout Antide pretreatment and the follicular stimulation cycle until the onset of menses for the determination of oestradiol and progesterone concentrations by radioimmunoassay (Zelinski-Wooten et al., 1997) . Serum samples were collected immediately prior to (0 h) and at 24, 48, 72 and 96 h following the r-HCG bolus, and at 0, 0.5, 1, 2, 4, 6, 8, 12, 24, 36, 48, 60, 72 and 96 h following the r-hFSH bolus. Serum concentrations of LH/CG were measured by an in-vitro mouse Leydig cell bioassay and FSH by the FSH MAIAClone Immunoradiometric assay kit (Serono Diagnostics, Coinsins, Switzerland) validated for macaque serum (Zelinski-Wooten et al., 1997) .
Follicle aspiration, oocyte evaluation and in-vitro fertilization
Follicles were aspirated by laparoscopy 27 h after the r-HCG or FSH bolus. Oocytes were recovered from the aspirates, and cumulus cells dispersed with hyaluronidase to allow classification of nuclear maturity (Wolf et al., 1990) . Oocytes collected at the metaphase II (MII) stage, those collected at the metaphase I (MI) stage that matured to MII within 8 h in vitro and those remaining at the MI stage 8 h post-collection were inseminated with motile, activated sperm and examined for fertilization after 16-18 h of culture (Wolf et al., 1990; Zelinski-Wooten et al., 1997) .
Progesterone production and expression of progesterone receptors by granulosa cells Luteinizing granulosa cells were isolated, purified and cultured in triplicate in Ham's F-10 medium (Gibco, Grand Island, NY, USA) containing 10% amenorrhoeic monkey serum in the absence (basal) or presence of HCG (100 ng/ml; CR123) as outlined previously (Aladin Chandrasekher et al., 1991) . Media were collected after 24 h of culture and frozen for measurement of progesterone concentration by radioimmunoassay.
Luteinizing granulosa cells (n ϭ 2 replicates/animal) were plated and frozen until analysis for progesterone receptors (PR) by indirect immunocytochemistry (Aladin Chandrasekher et al., 1991) . The percentage of nuclei staining for PR was determined by a random count of 500 cells.
Statistical analyses
Circulating steroid, HCG and FSH concentrations were transformed (to logarithm ϩ 1 or logarithm ϩ 10) prior to one-or two-way analyses of variance with one repeated measure, followed by unpaired Student's t-test for comparisons between treatment groups or paired Student's t-test for comparisons within treatment groups. The proportion of follicles at a given diameter and oocytes at various stages of nuclear maturity were compared between groups using the KruskalWallis test, followed by Fisher's exact test (when the numerator was Figure 1 . Serum oestradiol concentrations in gonadotrophin-treated monkeys destined to receive 1000 IU recombinant human chorionic gonadotrophin (r-HCG) or 2500 IU recombinant human follicle stimulating hormone (r-hFSH). The open rectangle represents the interval of r-hFSH ϩ Antide treatment to promote the development of multiple follicles, followed by r-HCG or r-hFSH (arrow) to induce periovulatory events. Data are plotted relative to the day of r-HCG/r-hFSH injection (day 0). Serum concentrations represent the mean Ϯ SEM (n ϭ 5/group). 5) or χ 2 analyses. The interval for follicular growth, number of follicles observed/animal, number of oocytes collected/animal, percentage oocyte recovery, average fertilization rates, media concentrations of progesterone, percentage of PR-positive cells and length of the luteal phase were compared using unpaired Student's t-tests. Differences were considered significant at P Ͻ 0.05. Values are presented as the mean Ϯ SEM.
Results
Figure 1 depicts serum oestradiol concentrations in gonadotrophin-treated monkeys destined to receive 1000 IU r-HCG or 2500 IU r-hFSH. In animals from both groups, serum oestradiol was at baseline for the first 4 days (days Ϫ12 to Ϫ8) of r-hFSH treatment, increased on day Ϫ7 (r-HCG) or day Ϫ6 (r-hFSH), and reached a plateau for the remainder of the follicular stimulation. Oestradiol concentrations did not differ significantly between animals receiving r-HCG (563 Ϯ 185 pg/ml) and r-hFSH (309 Ϯ 85 pg/ml) on the morning prior to the bolus injection (day 0). Oestradiol concentrations increased (P Ͻ 0.05) to a similar degree 24 h after the r-HCG and r-hFSH bolus. Following follicle aspiration, oestradiol concentrations declined and remained low during the luteal phase in both groups (data not shown).
The interval required to achieve multiple follicular growth according to predetermined criteria did not differ between animals receiving 1000 IU r-HCG (12 Ϯ 2 days) or 2500 IU r-hFSH (12 Ϯ 1 days). The total number of follicles/animal visualized by ultrasonography were similar between groups on the day of the r-HCG (30 Ϯ 4) or r-hFSH bolus (32 Ϯ 2). Likewise, the distribution of follicular sizes, expressed as a percentage of the total cohort, did not differ between the r-HCG and r-hFSH groups, being respectively: 2 mm, 26 versus 43%; 3 mm, 35 versus 27%; 4 mm, 21 versus 17%; 5 mm, 16 versus 9%; 6 mm, 1 versus 2%; 7 mm, 1 versus 1%; 8 mm, 1 versus 1%.
Circulating concentrations of bioactive LH/HCG or immunoreactive FSH in macaques that received 1000 IU r-HCG or 2500 IU r-hFSH as the ovulatory stimulus following follicular stimulation are shown in Figure 2 . Pretreatment (baseline) endogenous serum LH values generally ranged from 1.00 to 3.44 ng/ml in individual monkeys and did not differ between the treatment groups ( Figure 2, top panel) . In monkeys that received the r-HCG bolus, serum HCG increased (P Ͻ 0.05) within 0.5 h of injection, with peak concentrations evident at 2-8 h post-HCG. Bioactive HCG concentrations remained Ͼ100 ng/ml for 48 h after the r-HCG bolus, declining to 14.84 Ϯ 2.75 ng/ml by 96 h post-injection. In contrast, bioactive LH concentrations remained at baseline throughout the 96 h sampling interval after administration of the r-hFSH bolus (Figure 2, top panel) . In the r-HCG group, pretreatment (baseline) endogenous serum FSH concentrations were 12.8 Ϯ 1.2 mIU/ml and gradually declined (P Ͻ 0.05) to concentrations~1.2 mIU/ml at 96 h post-HCG injection (Figure 2, bottom panel) . In the rhFSH group, baseline FSH concentrations were 11.6 Ϯ 1.4 mIU/ml. Serum FSH increased (P Ͻ 0.05) within 0.5 h of FSH injection, reached peak concentrations by 2 h, remained unchanged for 8 h, and then declined to pretreatment concentrations by 96 h (Figure 2, bottom panel) . Table I summarizes the characteristics of oocytes collected from gonadotrophin-stimulated macaques 27 h after a bolus injection of r-HCG or r-hFSH. The mean number of oocytes collected/animal, percentage of oocytes recovered at follicle aspiration, as well as the proportions of atretic, immature (germinal vesicle-intact, prophase I), or mature (MI and MII) oocytes were similar between groups. The percentage of oocytes collected at the MI stage that matured to MII in vitro within 8 h was identical (24%) following 1000 IU r-HCG or 2500 IU r-hFSH. By 21 h post-collection (time of fertilization assessment), the majority of oocytes collected at the MI stage completed meiosis to the MII stage in both the r-HCG (90%) and r-hFSH (96%) groups. Fertilization rates were highly variable within each treatment group and ranged from 4 to 97% of oocytes inseminated. The average fertilization rates of oocytes inseminated at the various stages of nuclear maturity Figure 3 . In-vitro progesterone production by granulosa cells from monkeys that received 1000 IU recombinant human chorionic gonadotrophin (r-HCG) or 2500 IU recombinant human follicle stimulating hormone (r-hFSH). Cells were cultured for 24 h in the absence (basal) or presence of 100 ng/ml HCG. Values are the mean Ϯ SEM. Bars with different superscripts indicate significant (P Ͻ 0.05) differences in progesterone production between cells incubated in the absence or presence of HCG within a group.
as well as the total fertilization rates did not differ between groups (Table I) .
In-vitro progesterone production by granulosa cells from monkeys that received 1000 IU r-HCG or 2500 IU r-hFSH is shown in Figure 3 . Basal production of progesterone by granulosa cells over 24 h did not differ significantly between groups. The addition of HCG in vitro stimulated (P Ͻ 0.05) progesterone production relative to basal concentrations in both groups. Progesterone production by granulosa cells stimulated by HCG in vitro tended to be less (P ϭ 0.07) in the r-HCG (1.7-fold) group compared to the r-hFSH (2.4-fold) group.
No nuclear staining was observed when granulosa cells collected from animals in both groups were incubated with the control antibody (data not shown). A similar percentage of granulosa cell nuclei stained intensely positive for PR following the bolus of r-HCG (67 Ϯ 4%) relative to r-hFSH (76 Ϯ 5%).
Serum progesterone concentrations during the luteal phase in gonadotrophin-stimulated rhesus monkeys following administration of 1000 IU r-HCG or 2500 IU r-hFSH are depicted in Figure 4 . Progesterone concentrations increased (P Ͻ 0.05) within 24 h post-injection in both groups. Initially, concentrations of progesterone on days 1-5 of the luteal phase were similar between the r-HCG and r-hFSH groups, but concentrations were greater (P Ͻ 0.05) by day 6 following r-HCG compared with r-hFSH, and remained higher until day 10. The length of the luteal phase was similar following r-HCG (11 Ϯ 0.2 days) and r-hFSH (10 Ϯ 0.2 days).
Discussion
The present study is the first to report the efficacy of r-hFSH in place of HCG to induce nuclear maturation of oocytes capable of IVF and other periovulatory events at midcycle in gonadotrophin-stimulated macaques. These data obtained from primate follicles are consistent with those from rodent models wherein a bolus of FSH alone at midcycle can substitute for LH/CG to initiate early periovulatory events (Galway et al., 1990a; Tapanainen et al., 1993; Wang and Greenwald, 1993a; Montgomery-Rice et al., 1993) . In IVF-related cycles, regimens comprising r-hFSH alone can promote the development of multiple pre-ovulatory follicles, and when combined with HCG as the ovulatory stimulus, yield mature oocytes capable of fertilization in vitro and development to live offspring in non-human primates (Karnitis et al., 1994; Zelinski-Wooten et al., 1995; Weston et al., 1996) and women (Porchet and le Cotonnec, 1994; Balasch et al., 1995; Out et al., 1996; Shoham and Insler, 1996) . The present study demonstrates, for the first time in primates, that a regimen of r-hFSH alone which activates multiple follicular stimulation, can be combined with a bolus of FSH as an ovulatory stimulus to promote oocyte maturation and fertilization as well as early events in follicular luteinization.
Our study suggests that, in the non-human primate, a bolus of r-hFSH following follicular stimulation with r-hFSH was not detrimental to gamete function and was, in fact, equivalent to that of r-HCG with respect to oocyte nuclear maturation and fertilizability in vitro. While follicle-enclosed oocytes from PMSG-treated rats underwent germinal vesicle breakdown to a similar extent when exposed to either r-hFSH or r-hLH in vitro (Törnell et al., 1995) , reports on oocyte fertilization and embryo development after in vivo administration of a midcycle surge of r-hFSH in r-hFSH-primed mice are conflicting. Montgomery-Rice et al. (1993) observed high implantation rates with normal fetal development in-vivo in mature, pituitary-intact mice mated with fertile males, but Wang and Greenwald (1993a) noted a low frequency of fertilization and retarded in vitro development of preimplanta-tion embryos from hypophysectomized mice. The suboptimal effects of an in-vivo r-hFSH surge in the latter study may be attributable to: (i) a dose of r-hFSH that elicited delayed ovulation of aged oocytes incapable of development past the 2-cell stage post-fertilization; and/or (ii) difficulties in culturing early cleavage-stage mouse embryos to blastocysts in vitro (Wang and Greenwald, 1993a) .
Two early events in follicular luteinization of macaque follicles that occur within 27 h after HCG administration in IVF-related cycles, namely progesterone production and the expression of nuclear progesterone receptors (PR) by luteinizing granulosa cells (Aladin Chandrasekher et al., 1991) , were evident and equivalent following a bolus of r-hFSH relative to r-HCG at midcycle. A dose-dependent induction of PR expression (Natraj and Richards, 1993; Park-Sarge and Mayo, 1994) and progesterone production (Tapanainen et al., 1993) by rat granulosa cells was observed following r-hFSH administration in vivo or in vitro. Induction of these early events by the midcycle gonadotrophin surge prior to ovulation (HildPetito et al., 1988; Iwai et al., 1990; Aladin Chandrasekher et al., 1991) , coupled with our demonstration that progesterone is an obligatory mediator of the ovulatory process in primates (Hibbert et al., 1996) , support the possibility that a bolus of r-hFSH administered after follicular stimulation could elicit ovulation/follicular rupture in primates. Although we did not determine the efficacy of a r-hFSH bolus relative to r-HCG to culminate in this event in our non-human primate model, bona fide ovulation was documented by recovery of oocytes in the oviducts of rodents following a bolus of r-hFSH (Galway et al., 1990a; Montgomery-Rice et al., 1993; Tapanainen et al., 1993; Wang and Greenwald, 1993a) with associated increases in ovarian tissue-type plasminogen activator mRNA and enzyme activity (Galway et al., 1990b) , a potential participant in follicular rupture.
During spontaneous ovarian cycles, FSH and LH may act in concert during the midcycle gonadotrophin surge, or are redundant signals to ensure periovulatory events occur. Our data support the hypothesis of Yong et al. (1992) who proposed that cAMP can mediate divergent gonadotrophic effects on granulosa cell growth and differentiation by varying the intracellular 'tone' of this second messenger. Thus, it appears that primate granulosa cells (Yong et al., 1992) , like those of rodents (Richards and Hedin, 1988; Galway et al., 1990b; Natraj and Richards, 1993; Park-Sarge and Mayo, 1994) display different functional responses when exposed to low versus high concentrations of intracellular cAMP; the former stimulated primarily by FSH to evoke follicular growth, maturation and oestradiol production, and the latter to elicit oocyte maturation, luteinization and possibly follicle rupture regardless of the gonadotrophin stimulus. The cellular mechanism by which surge concentrations of FSH and LH/ CG elicit periovulatory events most likely involves cAMP activation of the protein kinase A pathway in granulosa cells (Natraj and Richards, 1993; Park-Sarge and Mayo, 1994) , either alone or in concert with the stimulation of protein kinase C or tyrosine kinase activity (Natraj and Richards, 1993; Shimamoto et al., 1993) .
Although FSH alone can induce both FSH and LH receptors 558 on granulosa cells in rodent follicles (Tapanainen et al., 1993; Wang and Greenwald, 1993b) , it is unlikely that the high concentrations of circulating FSH achieved after a bolus injection in macaques would act by binding to LH receptors on granulosa cells induced by this midcycle surge. First, r-hFSH was ineffective in displacing radiolabelled HCG binding to the human LH receptor transfected into Chinese hamster ovary cells, whereas the transfected receptor bound LH and HCG (Jia et al., 1991; Igarashi et al., 1994) . The highest concentration of r-hFSH used by Jia et al. (1991) that did not displace HCG binding to the hLH receptor was 3000 ng/ml, which is 10-to 25-fold higher than the maximum concentration of FSH circulating after injection of the r-hFSH bolus following gonadotrophin stimulation in macaques in our study. Second, r-hLH and hLH/CG were unable to displace labelled hFSH from the hFSH receptor transfected into human fetal kidney (Tilly et al., 1992) or Chinese hamster ovary cells and, unlike the addition of r-hFSH, did not elicit cAMP production. Third, the tendency for a greater-fold increase in progesterone production after in-vitro exposure to HCG by luteinizing granulosa cells obtained after the r-hFSH bolus (relative to the HCG stimulus in vivo) suggests that LH/ CG receptors were not occupied by r-hFSH. Fourth, r-hFSH stimulated progesterone release from human granulosa cells during superfusion in vitro (Rabe et al., 1996) . Since FSH receptors reside exclusively on granulosa cells in primate follicles (Kobayashi et al., 1990; Yamoto et al., 1992) , the role of theca cells during early events of luteinization in the primate follicle, as well as ovulation, is questioned. Alternatively, a bolus of FSH may stimulate granulosa cell responses that alter thecal function in a paracrine manner during luteinization (Hillier et al., 1995) . Evidence for this mechanism was provided by Smyth et al. (1995) in the rat whereby inhibin produced by granulosa cells mediates the ability of FSH to influence androgen synthesis by thecal cells. While the potential for FSH to alter thecal cell function via a paracrine factor emanating from the granulosa cell in primate follicles remains to be firmly established (Chappel and Howles, 1991) , evidence that FSH deprivation via administration of an FSH antiserum in vivo on day 6 of the menstrual cycle in bonnet monkeys prevented in-vitro responsiveness of both granulosa cells to FSH and theca cells to LH (Selvaraj and Moudgal, 1994) , supports this mechanism. Although a midcycle FSH surge promoted early events in granulosa cell luteinization, it was inadequate to sustain normal luteal function in primates. Decreased progesterone production following a bolus of r-hFSH in the present study could be related to the dose of r-hFSH used, a reduced half-life or biopotency of r-hFSH or inadequate recovery of endogenous LH secretion during midluteal phase. Alternatively, lack of progesterone production by theca-derived ('small') luteal cells, shown to be responsive to LH in vitro from macaque (Brannian and Stouffer, 1991) and human (Ohara et al., 1987) corpora lutea, may contribute to the reduced concentrations of progesterone circulating after the r-hFSH bolus. Although the corpus luteum is not typically considered a target of FSH action, Ohara et al. (1987) reported that 'large' luteal cells (presumably of granulosa origin) respond to FSH in vitro with increased aromatization of androgen substrate to oestradiol. However, there were no differences in serum oestradiol concentrations during the luteal phase following the midcycle bolus of r-hFSH relative to r-HCG in the present study. Whether production of luteal-derived, non-steroidogenic factors is altered in a similar fashion to progesterone after substitution of the midcycle gonadotrophin surge with r-hFSH alone is not presently known. Likewise, it is not clear whether the premature decline in progesterone production during the luteal phase after r-hFSH injection at midcycle would have physiological relevance for establishing pregnancy in primates. However, adequate progesterone was produced by corpora lutea to support implantation through late stages of pregnancy following a bolus of r-hFSH in r-hFSH-primed mice (Montgomery-Rice et al., 1993) .
In summary, a bolus of r-hFSH at midcycle was equivalent to r-HCG for the reinitiation of oocyte meiosis, fertilization and granulosa cell luteinization in GnRH antagonist-treated macaques administered r-hFSH alone for follicular stimulation. The data are consistent with rodent models wherein FSH can substitute for LH/CG to initiate early periovulatory events, but a midcycle FSH surge did not sustain normal luteal function in primates. Whether a midcycle FSH surge alone can evoke follicular rupture and oocyte release similar to LH/CG, as observed in rodents, remains to be tested in primates. Likewise, the efficacy of a r-hFSH bolus in IVF-related cycles for supporting ovarian/oocyte functions that result in normal embryonic development and production of live offspring in primates is unknown. The clinical utility of follicular stimulation/ovulation induction regimens composed solely of r-hFSH for reducing the incidence of ovarian hyperstimulation syndrome, improving IVF outcome in women with polycystic ovarian syndrome, avoiding systemic/local allergic reactions to urinary FSH preparations (Phipps et al., 1996) and initiating periovulatory events in LH-resistant patients (Latronico et al., 1996) are areas of future interest.
